| Cancer stem cells and HER2 positive breast cancer: The story so far D Shah, C Osipo Genes & diseases 3 (2), 114-123, 2016 | 63 | 2016 |
| Inhibition of HER2 increases JAGGED1-dependent breast cancer stem cells: role for membrane JAGGED1 D Shah, D Wyatt, AT Baker, P Simms, DS Peiffer, M Fernandez, E Rakha, ... Clinical Cancer Research 24 (18), 4566-4578, 2018 | 38 | 2018 |
| PKCα Attenuates Jagged-1–Mediated Notch Signaling in ErbB-2–Positive Breast Cancer to Reverse Trastuzumab Resistance K Pandya, D Wyatt, B Gallagher, D Shah, A Baker, J Bloodworth, A Zlobin, ... Clinical Cancer Research 22 (1), 175-186, 2016 | 37 | 2016 |
| Cytokine release syndrome and cancer immunotherapies–historical challenges and promising futures D Shah, B Soper, L Shopland Frontiers in Immunology 14, 1190379, 2023 | 11 | 2023 |
| Novel preclinical model for the evaluation of cytokine release syndrome in response to CD19xCD3 bispecific antibody in humanized mice DS Shah, C Simion, S hu, R Chronis, T McClellan, J Hwang, R Yang, ... Cancer Research 83 (7_Supplement), 4150-4150, 2023 | 1 | 2023 |
| Role of Jagged1 in the Enrichment of Cancer Stem Cells in HER2+ Breast Cancer DS Shah Loyola University Chicago, 2017 | 1 | 2017 |
| Targeting HER2 enriches Jagged1 high cancer stem cells in breast cancer DS Shah, D Wyatt, A Baker, A Green, A Filipovic, L Miele, C Osipo Cancer Research 77 (13_Supplement), 4769-4769, 2017 | | 2017 |
| Abstract P3-06-15: Notch3 as a predictor of GSI sensitivity in distinct subtypes of triple negative breast cancer D Shah, C Osipo Cancer Research 76 (4_Supplement), P3-06-15-P3-06-15, 2016 | | 2016 |
| Abstract P6-05-25: Ratio of notch receptors is critical for response to notch inhibition by a gamma-secretase inhibitor in triple negative breast cancer cells A Zlobin, R Kuprys-Olsauskas, D Shah, C Osipo Cancer Research 73 (24_Supplement), P6-05-25-P6-05-25, 2013 | | 2013 |
